Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 31;17(7):4732-4745.
doi: 10.21037/jtd-24-1703. Epub 2025 Jul 28.

Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China

Yunkang Zhao #  1 , Yao Wang #  1 , Yidun Zhang #  2 , Zeyu Zhao  1 , Buasiyamu Abudunaibi  1 , Kang Fang  1 , Huimin Qu  1 , Qiao Liu  1 , Yanhua Su  1 , Chenghao Su  2   3 , Zhinan Guo  2 , Tianmu Chen  1
Affiliations

Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China

Yunkang Zhao et al. J Thorac Dis. .

Abstract

Background: Recently, surges in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections in China have raised public concern. We investigated the epidemiological features and risk factors for SARS-CoV-2 reinfection in China.

Methods: A retrospective cohort study was conducted in Xiamen, China (2021-2023) with two subcohorts: Delta-Omicron (cohort 1) and Omicron-Omicron (cohort 2). Descriptive analysis and ensemble modeling were employed to evaluate reinfections.

Results: A total of 327 cases without fatalities were included. Reinfections accounted for 14.68% of cases, with 22.51% in cohort 1 and 3.68% in cohort 2. Compared with primary infections (PIs) (99.69% symptomatic, 56.54% hospitalized), reinfections were less severe, with fewer symptomatic instances (47.92%) and hospitalizations (4.65%). The majority of reinfections (83.33%) occurred following the relaxation of strict public health and social measures. The median time interval between PI and reinfection was longer for cohort 1 (462 days) than for cohort 2 (280 days). Reinfection risks were noted among lesser developed regions, those without persistent PI, those with primary Delta variant infection, government and hospital workers, and unvaccinated individuals.

Conclusions: SARS-CoV-2 reinfections are generally less severe and are influenced by the relaxation of control measures, viral evolution, and changing patterns of population immunity and contact; this underscores the need for ongoing surveillance and targeted public health strategies to manage future infection waves.

Keywords: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); coronavirus disease 2019 (COVID-19); primary infection (PI); reinfection.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-1703/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Epidemiological features of the SARS-CoV-2 reinfection. (A) The epidemic curve of the study population. (B) The distribution of key time intervals of SARS-CoV-2 reinfection. COVID-19, coronavirus disease 2019; PI, primary infection; RI, reinfection; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Tpr, the time interval between primary infection and reinfection; Tvr, the time interval from the most recent vaccination to the occurrence of reinfection.
Figure 2
Figure 2
Risk factors analysis of the SARS-CoV-2 reinfection. (A) Result of the optimal multivariate logistic regression for SARS-CoV-2 reinfection. (B) Result of the optimal GAM for SARS-CoV-2 reinfection. GAM, generalized additive model; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 3
Figure 3
The survival analysis for the SARS-CoV-2 reinfection. (A) The survival curve of the population examined for SARA-COV-2 reinfection. (B) Result of the univariate survival analysis and log-rank test for SARS-CoV-2 reinfection. (C) Result of the hierarchical analysis and log-rank test for SARS-CoV-2 reinfection. (D) Result of the optimal the optimal Cox proportional-hazards model for SARS-CoV-2 reinfection. KM, Kaplan-Meier; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
See this image and copyright information in PMC

References

    1. Lenharo M. WHO declares end to COVID-19's emergency phase. Nature 2023. [Epub ahead of print]. doi: . 10.1038/d41586-023-01559-z - DOI - PubMed
    1. Dhama K, Nainu F, Frediansyah A, et al. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4-14. 10.1016/j.jiph.2022.11.024 - DOI - PMC - PubMed
    1. Araf Y, Akter F, Tang YD, et al. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol 2022;94:1825-32. 10.1002/jmv.27588 - DOI - PMC - PubMed
    1. Servellita V, Syed AM, Morris MK, et al. Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants. Cell 2022;185:1539-1548.e5. 10.1016/j.cell.2022.03.019 - DOI - PMC - PubMed
    1. Andrews N, Stowe J, Kirsebom F, et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med 2022;386:1532-46. 10.1056/NEJMoa2119451 - DOI - PMC - PubMed